Weijun Shen

California Institute for Biomedical Research 
drug discovery, peptide engineering, cell biology, high throughput screening,
"Weijun Shen"
Mean distance: (not calculated yet)


Sign in to add mentor
David B. Berkowitz grad student 2001-2007 University of Nebraska - Lincoln
 (I. Development of a new assay and inhibitors for human cystathionine beta-synthase. II. Asymmetric catalyst development guided by in situ enzymatic screening (ISES).)
Peter G. Schultz post-doc 2007-2009 Scripps Research Institute
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yang Y, Lee C, Reddy RR, et al. (2022) Design of Potent and Proteolytically Stable Biaryl-Stapled GLP-1R/GIPR Peptide Dual Agonists. Acs Chemical Biology
Marrocco V, Tran T, Zhu S, et al. (2021) A small molecule UPR modulator for diabetes identified by high throughput screening. Acta Pharmaceutica Sinica. B. 11: 3983-3993
Sang P, Zeng H, Lee C, et al. (2021) α/Sulfono-γ-AApeptide Hybrid Analogues of Glucagon with Enhanced Stability and Prolonged In Vivo Activity. Journal of Medicinal Chemistry
Shalhout SZ, Yang PY, Grzelak EM, et al. (2021) YAP-dependent proliferation by a small molecule targeting annexin A2. Nature Chemical Biology
Lear S, Pflimlin E, Zhou Z, et al. (2020) Engineering of a Potent, Long-Acting NPY2R Agonist for Combination with a GLP-1R Agonist as a Multi-Hormonal Treatment for Obesity. Journal of Medicinal Chemistry
Liu YA, Jin Q, Ding Q, et al. (2020) A Dual Inhibitor of DYRK1A and GSK3β for β-Cell Proliferation: Aminopyrazine Derivative GNF4877. Chemmedchem
Lear S, Seo H, Lee C, et al. (2020) Recombinant Expression and Stapling of a Novel Long-Acting GLP-1R Peptide Agonist. Molecules (Basel, Switzerland). 25
Sang P, Zhou Z, Shi Y, et al. (2020) The activity of sulfono-γ-AApeptide helical foldamers that mimic GLP-1. Science Advances. 6: eaaz4988
Yang PY, Zou H, Amso Z, et al. (2020) New Generation Oxyntomodulin Peptides with Improved Pharmacokinetic Profiles Exhibit Weight Reducing and Anti-Steatotic Properties in Mice. Bioconjugate Chemistry
Liu YA, Jin Q, Zou Y, et al. (2020) Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133. Journal of Medicinal Chemistry
See more...